FDA Removes Warnings on Menopause Hormone Therapy, Boosting Access for Women
TL;DR
The FDA is removing the black box safety warnings on hormone therapy products for menopause, citing a more nuanced understanding of their benefits and risks, and emphasizing the potential health benefits of these therapies when prescribed appropriately. The decision follows public comments and studies suggesting hormone therapy can reduce risks of Alzheimer's, heart attack, and fractures, despite past concerns about cancer and stroke risks.
- The FDA will lift warnings on hormone therapy for menopause NPR
- ‘Black box’ safety warning to be removed from hormone therapy for menopause CNN
- Opinion | Marty Makary: The FDA Liberates Women’s Hormone Replacement Therapy The Wall Street Journal
- FDA chief says warning labels deterred women from using menopause hormone therapy: "It's an American tragedy" CBS News
- Hormone replacement therapy will no longer carry a warning label, FDA says NBC News
Want the full story? Read the original reporting
Read on NPR